Albertson D - Search Results

1

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.

Stenehjem DD, Hahn AW, Gill DM, Albertson D, Gowrishankar B, Merriman J, Agarwal AM, Thodima V, Harrington EB, Au TH, Maughan BL, Houldsworth J, Pal SK, Agarwal N. Stenehjem DD, et al. Among authors: albertson d. PLoS One. 2019 Jan 25;14(1):e0210415. doi: 10.1371/journal.pone.0210415. eCollection 2019. PLoS One. 2019. PMID: 30682039 Free PMC article.

2

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.

Tantravahi SK, Albertson D, Agarwal AM, Ravulapati S, Poole A, Patel SB, Hawatmeh JS, Straubhar AM, Liu T, Stenehjem DD, Agarwal N. Tantravahi SK, et al. Among authors: albertson d. J Oncol. 2015;2015:181926. doi: 10.1155/2015/181926. Epub 2015 Jan 20. J Oncol. 2015. PMID: 25688268 Free PMC article.

3

Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.

Merriman J, Tward J, Albertson D, Dechet C, Agarwal N. Merriman J, et al. Among authors: albertson d. J Immunother. 2016 Feb-Mar;39(2):101-3. doi: 10.1097/CJI.0000000000000106. J Immunother. 2016. PMID: 26849079

4

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.

Kuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N. Kuzman JA, et al. Among authors: albertson d. BMC Urol. 2017 Jan 5;17(1):1. doi: 10.1186/s12894-016-0192-0. BMC Urol. 2017. PMID: 28056941 Free PMC article.

5

Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.

Gupta S, Albertson D, Gaston D, Heilbrun ME, Agarwal N, Boucher K, Parnell TJ, Liu T, Morgans A, Madison R, Gowen K, Miller VA, Ross JS, Ali SM, Millis SZ. Gupta S, et al. Among authors: albertson d. Clin Genitourin Cancer. 2018 Apr;16(2):e373-e382. doi: 10.1016/j.clgc.2017.09.001. Epub 2017 Sep 7. Clin Genitourin Cancer. 2018. PMID: 28974397

6

Histologic Growth Patterns in Clear Cell Renal Cell Carcinoma Stratify Patients into Survival Risk Groups.

Sirohi D, Chipman J, Barry M, Albertson D, Mahlow J, Liu T, Raps E, Haaland B, Sayegh N, Li H, Rathi N, Sharma P, Agarwal N, Knudsen B. Sirohi D, et al. Among authors: albertson d. Clin Genitourin Cancer. 2022 Jun;20(3):e233-e243. doi: 10.1016/j.clgc.2022.01.005. Epub 2022 Jan 13. Clin Genitourin Cancer. 2022. PMID: 35125301 Free article.

7

Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway.

Mahlow J, Barry M, Albertson DJ, Jo YJ, Balatico M, Seasor T, Gebrael G, Kumar SA, Sayegh N, Tripathi N, Agarwal N, Swami U, Sirohi D. Mahlow J, et al. Among authors: albertson dj. Hum Pathol. 2024 Feb;144:28-33. doi: 10.1016/j.humpath.2024.01.005. Epub 2024 Jan 24. Hum Pathol. 2024. PMID: 38278448

8

Artificial intelligence chatbot vs pathology faculty and residents: Real-world clinical questions from a genitourinary treatment planning conference.

Luo MX, Lyle A, Bennett P, Albertson D, Sirohi D, Maughan BL, McMurtry V, Mahlow J. Luo MX, et al. Among authors: albertson d. Am J Clin Pathol. 2024 Jun 28:aqae078. doi: 10.1093/ajcp/aqae078. Online ahead of print. Am J Clin Pathol. 2024. PMID: 38940388

9

Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A-Mutated Advanced Urothelial Carcinoma.

Gupta S, Albertson DJ, Parnell TJ, Butterfield A, Weston A, Pappas LM, Dalley B, O'Shea JM, Lowrance WT, Cairns BR, Schiffman JD, Sharma S. Gupta S, et al. Among authors: albertson dj. Mol Cancer Ther. 2019 Jan;18(1):185-195. doi: 10.1158/1535-7163.MCT-17-0957. Epub 2018 Oct 9. Mol Cancer Ther. 2019. PMID: 30301863 Free PMC article.

10

PD-L1 Tumor Cell Expression in Upper Tract Urothelial Carcinomas is Associated With Higher Pathologic Stage.

Ward M, Albertson D, Furtado LV, Deftereos G. Ward M, et al. Among authors: albertson d. Appl Immunohistochem Mol Morphol. 2022 Jan 1;30(1):56-61. doi: 10.1097/PAI.0000000000000957. Appl Immunohistochem Mol Morphol. 2022. PMID: 34183505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters